Cargando…
Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282537/ https://www.ncbi.nlm.nih.gov/pubmed/32517796 http://dx.doi.org/10.1186/s13054-020-03027-w |
| _version_ | 1783544144016179200 |
|---|---|
| author | Tralhão, António Moita, Luís Ferreira Póvoa, Pedro |
| author_facet | Tralhão, António Moita, Luís Ferreira Póvoa, Pedro |
| author_sort | Tralhão, António |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7282537 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72825372020-06-10 Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt? Tralhão, António Moita, Luís Ferreira Póvoa, Pedro Crit Care Letter BioMed Central 2020-06-09 /pmc/articles/PMC7282537/ /pubmed/32517796 http://dx.doi.org/10.1186/s13054-020-03027-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter Tralhão, António Moita, Luís Ferreira Póvoa, Pedro Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt? |
| title | Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt? |
| title_full | Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt? |
| title_fullStr | Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt? |
| title_full_unstemmed | Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt? |
| title_short | Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt? |
| title_sort | potential benefit of angiotensin ii in covid-19 patients: beyond reasonable doubt? |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282537/ https://www.ncbi.nlm.nih.gov/pubmed/32517796 http://dx.doi.org/10.1186/s13054-020-03027-w |
| work_keys_str_mv | AT tralhaoantonio potentialbenefitofangiotensiniiincovid19patientsbeyondreasonabledoubt AT moitaluisferreira potentialbenefitofangiotensiniiincovid19patientsbeyondreasonabledoubt AT povoapedro potentialbenefitofangiotensiniiincovid19patientsbeyondreasonabledoubt |